How Pharmacists Can Drive Better Diabetes Outcomes Webinar

This two-part webinar explores how CGM can enhance patient care, reduce healthcare resource utilization, and improve long-term outcomes.

Publication Date June 18, 2026

Content category

Guidelines & Research

Product Training

Clinical focus

Veterans & Federal

Pharmacy

Type 2 Diabetes

This resource is intended for educational purposes only for healthcare providers practicing in the United States. It does not constitute medical advice and is not a substitute for professional judgment or individualized patient care. Recorded November 2025.

Executive Summary

This webinar provides pharmacists with an overview of Dexcom CGM technology and the clinical evidence informing its use in adult diabetes care.

Part 1: Innovations in CGM Technology & Recent Advances in Clinical Evidence

In this segment, Dr. Jennifer Bowles discusses:

Dexcom CGM design, accuracy evaluation, connectivity, and core glucose metrics relevant to medication management and patient education.
Evidence and guideline considerations for CGM use in type 2 diabetes, including insulin‑treated and non‑insulin‑treated populations.
CGM use in practice‑relevant populations, including pregnancy, veterans, chronic kidney disease, hypoglycemia risk, and economic considerations.

Video Timestamps

00:50 - Innovations in Dexcom CGM Technology

02:50 - How 15 Day Was Designed

03:40 - Pivotal Accuracy Study of 15.5 Day G7 & iCGM

08:08 - Dexcom Connectivity & Integration

08:40 - Glucose Management Indicator (GMI)

10:00 - Recent Advances in Clinical Evidence

11:15 - Guidelines for CGM Use in Pregestational and Gestational Diabetes

13:06 - Type 2 Diabetes Management in the 1st Year After Diagnosis

14:50 - CGM Use in the Veteran Population Using Insulin

16:12 - Problematic Hypoglycemia within the Noninsulin Type 2 Population

17:54 - Impact of CGM in Noninsulin Treated Patients

19:11- Economic Impact of CGM

21:34- CGM in Chronic Kidney Disease

23:12 - Impact of CGM on Mortality in T2D Patients

Part 2: The Dexcom Portfolio & Real-World Applications

In this segment, Dr. Brandon Ladd provides:

Overview of the Dexcom Portfolio, including Dexcom G7 15 Day and Stelo
Detailed discussion of key features and application to real-world care
Case-study featuring Dave, a 67-year old male newly diagnosed with type 2 diabetes
Review of support resources available to pharmacists, federal teams, and other healthcare providers

Video Timestamps

00:01 - Introducing the Dexcom Portfolio

04:44 - G7 Features, including Apple Watch, Alerts, Customizable Targets, and Food Logging

15:01 - Introducing Stelo and Key Features

19:13 - CGM and Medication Management

25:30 - Case Study: Newly Diagnosed with Type 2 Diabetes

28:56 - Factors Impacting Glucose Levels

29:57 - Education Resources and Summary